These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 14596612
1. Interaction of neuropeptide Y and Hsp90 through a novel peptide binding region. Ishiwatari-Hayasaka H, Maruya M, Sreedhar AS, Nemoto TK, Csermely P, Yahara I. Biochemistry; 2003 Nov 11; 42(44):12972-80. PubMed ID: 14596612 [Abstract] [Full Text] [Related]
2. Strongly altered receptor binding properties in PP and NPY chimeras are accompanied by changes in structure and membrane binding. Lerch M, Kamimori H, Folkers G, Aguilar MI, Beck-Sickinger AG, Zerbe O. Biochemistry; 2005 Jun 28; 44(25):9255-64. PubMed ID: 15966750 [Abstract] [Full Text] [Related]
3. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. Bader R, Bettio A, Beck-Sickinger AG, Zerbe O. J Mol Biol; 2001 Jan 12; 305(2):307-29. PubMed ID: 11124908 [Abstract] [Full Text] [Related]
4. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family. Zou C, Kumaran S, Markovic S, Walser R, Zerbe O. Chembiochem; 2008 Sep 22; 9(14):2276-84. PubMed ID: 18767100 [Abstract] [Full Text] [Related]
5. An unstructured C-terminal region of the Hsp90 co-chaperone p23 is important for its chaperone function. Weikl T, Abelmann K, Buchner J. J Mol Biol; 1999 Oct 29; 293(3):685-91. PubMed ID: 10543959 [Abstract] [Full Text] [Related]
6. Hsp90 is a direct target of the anti-allergic drugs disodium cromoglycate and amlexanox. Okada M, Itoh H, Hatakeyama T, Tokumitsu H, Kobayashi R. Biochem J; 2003 Sep 01; 374(Pt 2):433-41. PubMed ID: 12803546 [Abstract] [Full Text] [Related]
8. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY. Barden JA. Biochem Biophys Res Commun; 1995 Oct 04; 215(1):264-71. PubMed ID: 7575600 [Abstract] [Full Text] [Related]
10. The contribution of helical potential to the in vitro receptor binding activity of a neuropeptide Y N-terminal deletion fragment. Doughty MB, Hu L. Biopolymers; 1993 Aug 04; 33(8):1195-206. PubMed ID: 8364154 [Abstract] [Full Text] [Related]
13. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37. Roiniotis J, Masendycz P, Ho S, Scholz GM. Biochemistry; 2005 May 03; 44(17):6662-9. PubMed ID: 15850399 [Abstract] [Full Text] [Related]
14. A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90. Itoh H, Ogura M, Komatsuda A, Wakui H, Miura AB, Tashima Y. Biochem J; 1999 Nov 01; 343 Pt 3(Pt 3):697-703. PubMed ID: 10527951 [Abstract] [Full Text] [Related]
18. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Ren J, Bharti A, Raina D, Chen W, Ahmad R, Kufe D. Oncogene; 2006 Jan 05; 25(1):20-31. PubMed ID: 16158055 [Abstract] [Full Text] [Related]
19. HSP90, HSP70, and GAPDH directly interact with the cytoplasmic domain of macrophage scavenger receptors. Nakamura T, Hinagata J, Tanaka T, Imanishi T, Wada Y, Kodama T, Doi T. Biochem Biophys Res Commun; 2002 Jan 18; 290(2):858-64. PubMed ID: 11785981 [Abstract] [Full Text] [Related]
20. HBV polymerase interacts independently with N-terminal and C-terminal fragments of Hsp90beta. Cho G, Suh SW, Jung G. Biochem Biophys Res Commun; 2000 Jul 21; 274(1):203-11. PubMed ID: 10903919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]